REQUEST A DEMO
Total
USD $0.00
Search more companies

Wama Pharma S.A.S. (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Wama Pharma S.A.S. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Wama Pharma S.A.S. is a company in Colombia, with a head office in Bogota D.C.. It operates in the Pharmacies and Drug Stores industry. It was first established on June 05, 2017. 6 (2024) employees currently work for Wama Pharma S.A.S.. The latest financial highlights indicate a net sales revenue increase of 45.21% in 2023. There was a total negative growth of 7.22% in Wama Pharma S.A.S.’s total assets over the same period. The net profit margin of Wama Pharma S.A.S. decreased by 10.39% in 2023.

Headquarters
Calle 127A # 53A - 45 Piso 6 Oficina 06-114. Edificio Centro Empresarial Colpatria Torre 2
Bogota D.C.; Bogota D.C; Postal Code: 1016

Contact Details: Purchase the Wama Pharma S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Wama Pharma S.A.S. report to view the information.
Outstanding Shares:
Purchase the Wama Pharma S.A.S. report to view the information.
Incorporation Date:
June 05, 2017
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Wama Pharma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
45.21%
Total operating revenue
45.21%
Operating profit (EBIT)
662.66%
Net Profit (Loss) for the Period
-75.81%
Total assets
-7.22%
Total equity
-5.81%
Operating Profit Margin (ROS)
66.03%
Net Profit Margin
-10.39%
Return on Equity (ROE)
-38.77%
Quick Ratio
-0.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?